featured
Association of Cumulative Disease Damage and Anti-PM/Scl Antibodies With a Heavy Burden of Calcinosis in Systemic Sclerosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Rheumatology (Oxford, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cumulative Disease Damage and Anti-PM/Scl Antibodies Are Associated with a Heavy Burden of Calcinosis in Systemic Sclerosis
Rheumatology (Oxford) 2022 Dec 05;[EPub Ahead of Print], C Richardson, J Perin, S Zeger, FM Wigley, LK Hummers, L Casciola-Rosen, A Rosen, AA ShahFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.